Filter

Transactions and Public Offerings

Pluristem Therapeutics Ltd. received a public offering at a value of $17.25 million

Pluristem Therapeutics Ltd. received a public offering at a value of $17.25 million

 ZAG-S&W Intl team headed by Oded Har-Even & Howard Berkenblit along with attorneys: Ron Ben-Bassat, Shy Baranov, Eran Ben-Dor & Hila Barzelay-Nahum led Pluristem Therapeutics to a public offering of its common stock and warrants.

January, 2017 

Capital Raising for Insuline Medical ltd. at a sum of NIS 8,192,930

Capital Raising for Insuline Medical ltd. at a sum of NIS 8,192,930

Attorneys Eran Ben-Dor & Reut Alfiah consulted the company throughout the process to recieve the Capital funding .

Insuline Medical is a publicly-listed Israeli medical device company, which has developed a device that enables patients on intensive insulin therapy to take control of their disease and reach treatment targets in a more effective and safer manner.
January, 2017
HBL- Hadasit Bio-Holdings raised NIS 4.8 in a right offering

HBL- Hadasit Bio-Holdings raised NIS 4.8 in a right offering

Attornyes Eran Ben-Dor and Lital Slutzky represented the company.

Hadasit Bio-Holdings Ltd serves as a precedent in biotechnology financing for the first time, public investment is allowed to participate in companies based on IP generated by Israel's foremost medical research center - the Hadassah University Hospital  which is responsible for the majority of Israel's hospital-based research.

January, 2017

ZAG-S&W Team represented DarioHealth Corp. in a private placement on Nasdaq, in an aggregate price of $5.1 million

ZAG-S&W Team represented DarioHealth Corp. in a private placement on Nasdaq, in an aggregate price of $5.1 million

Attornyes Oded Har-Even, Ron Ben-Bassat and Robert Condon represented DarioHealth Corp. in the private placement.

The deal was led by OurCrowd Qure, a dedicated digital health fund.

January, 2017

Read more
ZAG-S&W represented Aegis Capital Corp. as Lead Placement Agent in a private placement offering of Rosetta Genomics

ZAG-S&W represented Aegis Capital Corp. as Lead Placement Agent in a private placement offering of Rosetta Genomics

Attornyes Oded Har-Even, Shy Baranov, Rob Condon, Ron Ben-Bassat and Hila Nahum represented Aegis Capital Corp. as Lead Placement Agent in an approximately $5 million concurrent registered direct and private placement offering of ordinary shares, debentures and warrants by Rosetta Genomics, which develops and commercializes a full range of microRNA-based and other molecular diagnostics.

December, 2016

ZAG-S&W represented Aegis Capital Corp. as Lead Placement Agent in a private placement offering of Rennova Health Inc.

ZAG-S&W represented Aegis Capital Corp. as Lead Placement Agent in a private placement offering of Rennova Health Inc.

Attornyes Oded Har-Even, Shy Baranov, Rob Condon, Ron Ben-Bassat and Hila Nahum represented Aegis Capital Corp. as Lead Placement Agent in an approximately $12.4 million private placement offering of preferred shares By Rennova Health Inc. 

December, 2016

ZAG-S&W represented Roth Capital as Underwriter in $8.2 million offering of Light Path Technologies Inc.

ZAG-S&W represented Roth Capital as Underwriter in $8.2 million offering of Light Path Technologies Inc.

Attornyes Oded Har-Even, Rob Condon and Hila Nahum represented Roth Capital.

December, 2016

ZAG-S&W represented Roth Capital as underwriter in Top Image System private placecment

ZAG-S&W represented Roth Capital as underwriter in Top Image System private placecment

Attorney Oded Har-Even represented Roth Capital in a $5 million private placement of Top Image System.

December, 2016

The firm represented HBL Hadasit Bio-Holdings Ltd. in a fund raising of approximately $1 million

The firm represented HBL Hadasit Bio-Holdings Ltd. in a fund raising of approximately $1 million

Attorneys Eran Ben Dor and Lital Slutzky represented the company.

September, 2016
ZAG-S&W Team represented Nano Dimension Ltd. in its public offering of approximately $13.8 million

ZAG-S&W Team represented Nano Dimension Ltd. in its public offering of approximately $13.8 million

The ZAG-S&W team included Oded Har-Even, Howard Berkenblit, Rob Condon, Shy Baranov, David Huberman, Ron Ben-Bassat and Hila Nahum.

September, 2016

Our firm served as U.S. counsel to Medigus Ltd. in a registered direct offering with gross proceeds of approximately $1.47 million

Our firm served as U.S. counsel to Medigus Ltd. in a registered direct offering with gross proceeds of approximately $1.47 million

The team includud Oded Har-Even, Robert Condon, Ron Ben Bassat and Leigh Sapir-Kashi. Roth Capital Partners acted as the lead placement agent and Maxim Group LLC acted as the co-placement agent for this transaction.

September, 2016

The firm represented IceCure Medical Ltd. in a fund raising

The firm represented IceCure Medical Ltd. in a fund raising

Attorneys Eran Ben-Dor and Reut Alfia, represented the company's successful fund raising of a total of $6 million.

September, 2016

Insuline Medical Ltd. raised additional NIS2.2 million

Insuline Medical Ltd. raised additional NIS2.2 million

Attorneys Eran Ben-Dor and Reut Alfia represented the company in the financing round.

August, 2016

Attorneys Mor Limanovich and Marie Orlovsky represented Zeekit Ltd. in a finanacing round of $9 million

Attorneys Mor Limanovich and Marie Orlovsky represented Zeekit Ltd. in a finanacing round of $9 million

the team represented the company in the Negotiation and drafted the investment transaction documents.

August, 2016

ZAG-S&W Team represented Cellect Biotechnology Ltd. in it’s IPO on NASDAQ

ZAG-S&W Team represented Cellect Biotechnology Ltd. in it’s IPO on NASDAQ

A ZAG-S&W Team represented Cellect Biotechnology Ltd.  in its initial public offering in the United States of 1,292,308 American Depository Shares (ADSs) and warrants to purchase up to 969,231 ADSs. 

The gross proceeds to Cellect from this offering are $8.4 million. 

July, 2016

The firm represented Micronet Enertec in a $2.4 million offering of ”Standby Equity Distribution Common Stock”

The firm represented Micronet Enertec in a $2.4 million offering of ”Standby Equity Distribution Common Stock”

Attorneys Oded Har-Even, Howard Berkenblit, Rob Condon and Ron Ben Bassat represented the company.

July, 2016

The firm represented the US investment bank Gunner & Joseph in a public offering of Rennova Health.

The firm represented the US investment bank Gunner & Joseph in a public offering of Rennova Health.

Attorneys Oded Har-Even, Rob Condon, Hila Nahum, Jene Schlack and Ron Ben-Bassat, represented Gunner & Joseph who served as an underwriter in the offering.

July, 2016

Our firm represented ”HaMashbir 365 Holdings Ltd.” in a sale of it’s control of Aviation Links Ltd.

Our firm represented ”HaMashbir 365 Holdings Ltd.” in a sale of it’s control of Aviation Links Ltd.

Adv. Ifat Nir Katz represented the company in the transaction worth $9 million.

July, 2016

The firm represented the US investment bank Renshaw & Rodman as an underwriter in a public offering of $12 million

The firm represented the US investment bank Renshaw & Rodman as an underwriter in a public offering of $12 million

Attorneys Oded Har-Even, Shy Baranov, Rob Condon, David Huberman and Ron Ben-Bassat, represented Renshaw & Rodman.

June, 2016

Our firm represented EasyPark, a Swedish company, in it’s acquisition of the Israeli company, Parko

Our firm represented EasyPark, a Swedish company, in it’s acquisition of the Israeli company, Parko

Adv. Eran Ben-Dor represented the Swedish company EasyPark in the transaction.

June, 2016

 
Our Capital Markets attornyes represented Radcom Ltd. in it’s $23 million public offering of ordinary shares

Our Capital Markets attornyes represented Radcom Ltd. in it’s $23 million public offering of ordinary shares

Attorneys Oded Har Even, Howard Berkenblit and David Huberman  represented RADCOM Ltd. In an underwritten public offering of approximately $23 million. ZAG-S&W handled the transaction in its entire legal and business aspects.

May, 2016

Adv. Mor Limanovich represented KIDOZ in a financing round of $1 million

Adv. Mor Limanovich represented KIDOZ in a financing round of $1 million

KIDOZ is a global network helping millions of kids safely play games and watch videos online. 

The money was raised from private investors.

May, 2016

 
Insuline Medical Ltd. raised approximately NIS4 million

Insuline Medical Ltd. raised approximately NIS4 million

Attornyes Eran Ben-Dor and Reut Alfia represented the company.

May, 2016

The firm represented Mazor Robotics Ltd., in a strategic and complex equity investment by Medtronic

The firm represented Mazor Robotics Ltd., in a strategic and complex equity investment by Medtronic

Attornyes Oded Har-Even, Howard Berkenblit, Rob Condon and David Huberman represented  the company. Mazor Robotics Ltd. is traded on the TASE and NASDAQ.

May, 2016

Signals Intelligence Group raised $5.25 million from Qumra

Signals Intelligence Group raised $5.25 million from Qumra

Adv. Mor Limanovich represented the company.

May, 2016

The firm represented the investment bank Chardan Capital Markets as an underwriter in a public offering of $10 million

The firm represented the investment bank Chardan Capital Markets as an underwriter in a public offering of $10 million

Attorneys Oded Har-Even, Rob Condon and Hila Nahum represented the Bank on a public offdering of VistaGen Therapeutics, a biomed company that develops products for the treatment of diseases related to the nervous system.

May, 2016

Adv. Mor Limanovich represented XJET Ltd. in a financing round of $25 million

Adv. Mor Limanovich represented XJET Ltd. in a financing round of $25 million

At the financing round participated Catalyst CEL, Autodesk and former investors from previous financing rounds.

March, 2016

ZAG-S&W represented BioBlast Pharma Ltd.

ZAG-S&W represented BioBlast Pharma Ltd.

Attornyes Oded Har-Even, Shy Baranov, Robert Condon, David Huberman and Hila Nahum represented the company as issuer's counsel in a certain registered direct offering for an aggregate price of $6.7M. Roth Capital and Rodman & Renshaw acted as co-placement agents for the offering.

March, 2016

ZAG-Sַ&W represented Summit Real Estate Group Ltd. in a private placement worth $120 million

ZAG-Sַ&W represented Summit Real Estate Group Ltd. in a private placement worth $120 million

Attorneys Gal Chet, Gil Lavron and Nathalie Raccah represented the company in the private placement

March, 2016

Adv. Eran Ben-Dor represented Raziel Therapeutics in a financing round of $4.5 million from Pontifax Ltd.

Adv. Eran Ben-Dor represented Raziel Therapeutics in a financing round of $4.5 million from Pontifax Ltd.

Raziel Therapeutics has developed technology enabling to dissolve fats in the human body through injections.

February, 2016

ZAG-S&W represented Polypid Ltd. in completion of $22 Million private equity financing

ZAG-S&W represented Polypid Ltd. in completion of $22 Million private equity financing

The financing was co-led by new investor Shavit Capital and current investor Aurum Ventures. The round also included participation of Chaim Hurvitz who will now head the Company’s board of directors, as well as other existing shareholders.

February, 2016

Attorneys Oded Har-Even, David Huberman and Robert Condon represented Nano Dimension Ltd.

Attorneys Oded Har-Even, David Huberman and Robert Condon represented Nano Dimension Ltd.

Nano Dimension Ltd. (NNDM), a leader in the area of 3D printed electronics, uplisted its American Depositary Shares (ADSs) to the NASDAQ Capital Market under the symbol “NNDM,” effective on March 7, 2016. Nano Dimension’s ordinary shares also trade on the Tel Aviv Stock Exchange. 

March, 2016

Attornyes Ifat Nir Katz, Gil Lavron and Nathalie Raccah represented Hamashbir Holdings, as an issuer’s counsel in a public bond offering, in the amount of $23 million.

Attornyes Ifat Nir Katz, Gil Lavron and Nathalie Raccah represented Hamashbir Holdings, as an issuer’s counsel in a public bond offering, in the amount of $23 million.

January, 2016

 

Adv. Mor Limanovich represented NSLComm in a financing round of $2.5 million from JVP and additional investors

Adv. Mor Limanovich represented NSLComm in a financing round of $2.5 million from JVP and additional investors

NSLComm in an Israeli start up which focuses on satellite communication.

January, 2016

ZAG-S&W represented Aegis Capital Corp. in a $10 Million public offering of common stock, warrants and convertible preferred stock for Rennova Health Inc.

ZAG-S&W represented Aegis Capital Corp. in a $10 Million public offering of common stock, warrants and convertible preferred stock for Rennova Health Inc.

Aegis Capital Corp. is an investment bank and underwriter.  Rennova Health's common stock and warrants are listed on the NASDAQ Capital Market.

December, 2015

Attornyes Eran Ben-Dor and Reut Alfia represented RH Technologies in a Tender Offer

Attornyes Eran Ben-Dor and Reut Alfia represented RH Technologies in a Tender Offer

Attornyes Eran Ben-Dor and Reut Alfia acted as legal counsel of the controlling shareholders of the company in a Tender Offer under Section 336 of the Israeli Company's act, which was aimed to privatize the company.

December, 2015

 

The firm represented HBL Hadasit Bio-Holdings Ltd. in a fund raising of apprx. $2 million

The firm represented HBL Hadasit Bio-Holdings Ltd. in a fund raising of apprx. $2 million

Attorneys Eran Ben-Dor and Reut Alfia represented the company. This is the company's 3rd financing in 2015.

December, 2015

Moovex raises $1.25 million

Moovex raises $1.25 million

Adv. Eran Ben-Dor represented the company in the financing round.

December, 2015

SimilarWeb acquires Quettra in approximately $10 million

SimilarWeb acquires Quettra in approximately $10 million

Attornyes Mor Limanovich and Natalie Raccah form our Tel Aviv offices and Lewis Segal from our Boston offices, represented SimilarWeb in the transaction

December, 2015

ZAG-S&W represented Alcobra Ltd. in a public offering

ZAG-S&W represented Alcobra Ltd. in a public offering

Attorneys Oded Har-Even, Shy Baranov, Howard Berkenblit, David Huberman and Hila Nahum represented Alcobra Pharma as issuer's counsel in an Underwritten Public Offering of approximately aggregate offering price of $42M. Jefferies LLC and Barclays Capital Inc. acted as joint book-running managers for the offering.

November, 2015

 

JOIN REAL raised $6 million

JOIN REAL raised $6 million

Attornyes Mor Limanovich and Marie Orlovsky provided the company with comprehensive legal assistance in its recent financing round, in the share purchase agreement with Magma Venture Capital IV L.P. and Magma Venture Capital IV CEO Fund L.P.

November, 2015

The firm represented Signals Group in a financing roung of $15 million

The firm represented Signals Group in a financing roung of $15 million

Attorneys Mor Limanovitz and Marie Orlovski represented the company in afinancing transaction (second round of financing) of $15 million. The round was led by venture capital firm Sequoia Capital and existing investor TPY Capital.

October, 2015

Adv. Eran Ben-Dor represented Endospan Ltd. in a financing round of $10 million

Adv. Eran Ben-Dor represented Endospan Ltd. in a financing round of $10 million

The second largest Medical Corporation in China, will receive exclusive marketing rights in the country. Endospan is an Israeli medical device company developing innovative implants for the treatment of the aorta.

October, 2015

Insuline Medical Ltd. raised approximately $1.2 million

Insuline Medical Ltd. raised approximately $1.2 million

Attorneys Eran Ben-Dor and Reut Alfia represented the company.

August, 2015

ZAG-S&W represented Pluristem Therapeutics Inc. as Issuer’s Counsel in a certain registered direct offering in an aggregate amount of $17M

ZAG-S&W represented Pluristem Therapeutics Inc. as Issuer’s Counsel in a certain registered direct offering in an aggregate amount of $17M

The team who lead the offering includes Oded Har-Even, Shy Baranov, Howard Berkenblit and Adi Osovsky. Maxim Group LLC acted as lead placement agent for the offering.

June, 2015

 

The Capital Markets Department in our offices in the US represrnted ClickSoftware

The Capital Markets Department in our offices in the US represrnted ClickSoftware

Attorneys Oded Har-Even and Howard Berkenblit from our U.S. Capital Markets department, represented the company in it's acquisition by Francisco Partners L.P  in an amount of $438 million.

May, 2015

Another successful financing round of $25 million for SimilarWeb

Another successful financing round of $25 million for SimilarWeb

Adv. Mor Limanovich represented the company in another financing round from it's current investors.

May, 2015

Attornyes Eran Ben-Dor and Reut Alfia represented HBL - Hadasit Bio-Holdings Ltd. in a public offering of $1.1 million

Attornyes Eran Ben-Dor and Reut Alfia represented HBL - Hadasit Bio-Holdings Ltd. in a public offering of $1.1 million

April,  2015

Our firm represented both Epoch Partner Investment Ltd. and IceCure Medical (the issuar) in a total amount of $5.5M, of shares and warrants

Our firm represented both Epoch Partner Investment Ltd. and IceCure Medical (the issuar) in a total amount of $5.5M, of shares and warrants

Attornyes Eran Ben-Dor and Reut Alfiah, represented the private placement of Epoch Partner Investment Ltd., in IceCure Medical Ltd. ina total amount of $5.5 million of shares and warrants. Our firm represented both parties of the transaction. 

February, 2015

Alcobra Ltd. raised another $29.9 million.

Alcobra Ltd. raised another $29.9 million.

The firm represented Alcobra in an additional public offering of $29.9 million.

January, 2015

The firm represented Coloright in it’s acquisition By L’Oreal in an amount of $100 million

The firm represented Coloright in it’s acquisition By L’Oreal in an amount of $100 million

Adv. Mor Limanovich represented the start-up company Coloright, which was founded in 2002 by Mr. Benny Landa, in the agreement.

December, 2014